BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30542718)

  • 21. Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases.
    Zeng JH; Xiong DD; Pang YY; Zhang Y; Tang RX; Luo DZ; Chen G
    Oncotarget; 2017 May; 8(22):35681-35699. PubMed ID: 28415685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma.
    Chen WJ; Gan TQ; Qin H; Huang SN; Yang LH; Fang YY; Li ZY; Pan LJ; Chen G
    Pathol Res Pract; 2017 Apr; 213(4):364-372. PubMed ID: 28214218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
    Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G
    World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Clinicopathological Significance and Correlative Signaling Pathways of an Autophagy-Related Gene, Ambra1, in Breast Cancer: a Study of 25 Microarray RNA-Seq Datasets and in-House Gene Silencing.
    He RQ; Xiong DD; Ma J; Hu XH; Chen G; Sun WL
    Cell Physiol Biochem; 2018; 51(3):1027-1040. PubMed ID: 30476925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene Expression Analysis Reveals Key Genes and Signalings Associated with the Prognosis of Prostate Cancer.
    Shen H; Guo YL; Li GH; Zhao W; Zhang L
    Comput Math Methods Med; 2021; 2021():9946015. PubMed ID: 34497666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of miRNA-205 Expression and Biological Mechanism in Prostate Cancer Tumorigenesis and Bone Metastasis.
    Sun Y; Li SH; Cheng JW; Chen G; Huang ZG; Gu YY; Yan HB; He ML
    Biomed Res Int; 2020; 2020():6037434. PubMed ID: 33178832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma.
    Gao Z; Man X; Li Z; Bi J; Liu X; Li Z; Zhu Y; Zhang Z; Kong C
    Oncol Rep; 2019 Apr; 41(4):2440-2452. PubMed ID: 30816525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of upregulated miR-375 expression in breast cancer: An in vitro and in silico study.
    Tang W; Li GS; Li JD; Pan WY; Shi Q; Xiong DD; Mo CH; Zeng JJ; Chen G; Feng ZB; Huang SN; Rong MH
    Pathol Res Pract; 2020 Jan; 216(1):152754. PubMed ID: 31787478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.
    Ren FH; Yang H; He RQ; Lu JN; Lin XG; Liang HW; Dang YW; Feng ZB; Chen G; Luo DZ
    BMC Cancer; 2018 Jan; 18(1):12. PubMed ID: 29298665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data.
    Liang L; Gao L; Zou XP; Huang ML; Chen G; Li JJ; Cai XY
    Mol Med Rep; 2018 Feb; 17(2):2297-2312. PubMed ID: 29207053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulated miR‑203a‑3p and its potential molecular mechanism in breast cancer: A study based on bioinformatics analyses and a comprehensive meta‑analysis.
    Cai KT; Feng CX; Zhao JC; He RQ; Ma J; Zhong JC
    Mol Med Rep; 2018 Dec; 18(6):4994-5008. PubMed ID: 30320391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic values of GPNMB identified by mining TCGA database and STAD microenvironment.
    Yao K; Wei L; Zhang J; Wang C; Wang C; Qin C; Li S
    Aging (Albany NY); 2020 Aug; 12(16):16238-16254. PubMed ID: 32833670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data.
    Gan TQ; Xie ZC; Tang RX; Zhang TT; Li DY; Li ZY; Chen G
    Tumour Biol; 2017 Mar; 39(3):1010428317691683. PubMed ID: 28347234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of miR‑133a‑3p as a diagnostic indicator for hepatocellular carcinoma: An investigation combined with GEO, TCGA, meta‑analysis and bioinformatics.
    Liang HW; Yang X; Wen DY; Gao L; Zhang XY; Ye ZH; Luo J; Li ZY; He Y; Pang YY; Chen G
    Mol Med Rep; 2018 Jan; 17(1):1469-1484. PubMed ID: 29138825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data.
    Zhan C; Yan L; Wang L; Jiang W; Zhang Y; Xi J; Jin Y; Chen L; Shi Y; Lin Z; Wang Q
    Dis Esophagus; 2016 Nov; 29(8):920-928. PubMed ID: 26402921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
    Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
    J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The biological functions of target genes in pan-cancers and cell lines were predicted by miR-375 microarray data from GEO database and bioinformatics.
    Zeng JH; Liang XZ; Lan HH; Zhu X; Liang XY
    PLoS One; 2018; 13(10):e0206689. PubMed ID: 30379973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic role of miR‑183‑5p in lung adenocarcinoma: A comprehensive study of qPCR, in vitro experiments and bioinformatic analysis.
    He RQ; Gao L; Ma J; Li ZY; Hu XH; Chen G
    Oncol Rep; 2018 Jul; 40(1):83-100. PubMed ID: 29749535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
    Wen DY; Lin P; Pang YY; Chen G; He Y; Dang YW; Yang H
    Med Sci Monit; 2018 May; 24():2786-2808. PubMed ID: 29728556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancer.
    Zhang W; Shu P; Wang S; Song J; Liu K; Wang C; Ran L
    Gene; 2018 Oct; 675():136-143. PubMed ID: 29966681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.